Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

What’s in a name?

Executive Summary

Public workshop on premarket drug name safety testing, co-sponsored by FDA, the Pharmaceutical Research & Manufacturers of America, and the Institute for Safe Medication Practices, is scheduled for June 26. The meeting is being held to discuss ways to improve the process of premarket drug name testing for safety. FDA's draft "Premarketing Risk Assessment" concept paper proposes that sponsors conduct a "medication error prevention" analysis to assess the risk potential of the drug name prior to approval (1"The Pink Sheet" March 10, p. 5)...

You may also be interested in...



Drug Name Errors Workshop Will Focus On Study Design Of Premarket Tests

An FDA public meeting on drug name errors will focus on how to design premarket trials to detect potential problems

Rx Name Risk Assessments Should Be Conducted By Manufacturers, FDA Says

Drug and biologic sponsors should conduct a risk assessment on the product's name, labeling and packaging to minimize medication errors, an FDA concept paper states

Health And Wellness Trademark Review 14 January, 2020

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
UsernamePublicRestriction

Register

PS041832

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel